Assay for Marketed formulation
A validated stability indicating LC-MS compatible RP-HPLC assay and dissolution methods for marketed formulation Stribild
12
“TO DEVELOP AND VALIDATE ASSAY METHODS FOR THE ESTIMATION OF HALOBETASOL PROPIONATE AND MICONAZOLE NITRATE IN MARKETED FORMULATION”
23
Formulation and Comparative Evaluation of Proniosome Hydrocortisone Gel with Marketed Formulation
108
VALIDATED SPECTROPHOMETRIC METHOD FOR THE ESTIMATION OF PREGABALIN IN MARKETED FORMULATION
5
Liquid Chromatography and Spectroscopic Method for Estimation of Sulphadoxine in Marketed Formulation
8
HPTLC METHOD DEVELOPMENT AND VALIDATION OF CINNARIZINE IN BULK AND MARKETED FORMULATION
7
Stability indicating method development for the estimation of diloxanide furonate in marketed formulation
11
Development and Validation of Stability Indicating HPLC Method for Estimation of Dapagliflozin in Marketed Formulation
22
COMPARATIVE BIOEQUIVALENCE STUDIES OF CINNARIZINE AND ITS DIFFERENT AVAILABLE MARKETED FORMULATION DRUGS
7
DEVELOPMENT OF NEW COLORIMETRIC METHOD AND VALIDATION FOR DETERMINATION OF LOPERAMIDE IN BULK AND MARKETED FORMULATION
12
SIMULTANEOUS ESTIMATION OF ACEBROPHYLLINE, MONTELUKAST AND LEVOCETRIZINE DIHYDROCHLORIDE IN MARKETED FORMULATION BY UV-SPECTROSCOPY
11
Investigation of selected medicinal plants and marketed formulation for their anti-inflammatory and anti-osteoarthritis activity.
129
SIMULTANEOUS DETERMINATION AND VALIDATION OF HYDROCHLORTHIAZIDE & CANDESARTAN IN BULK DRUG AND MARKETED FORMULATION BY RP HPLC
11
Development and Validation of HPTLC Method for Simultaneous Quantification of Aspirin and Omeprazole in Bulk and Marketed Formulation
8
DEVELOPMENT AND VALIDATION OF A RP HPLC METHOD FOR ASSAY OF LINAGLIPTIN IN BULK AND MARKETED DOSAGE FORM
11
Formulation and pharmacopoeial quality evaluation of ketorolac tromethamine IR tablet and comparison with marketed product
6
PHARMACOLOGICAL EVALUATION OF MARKETED POLYHERBAL FORMULATION
6
STANDARDIZATION OF MARKETED AMRITARISHTA- A HERBAL FORMULATION
8
Comparative Study of Herbal Formulation and Marketed Formulation of Triphala Churna
9
DIFFERENCE SPECTROSCOPIC ESTIMATION OF LOMEFLOXACIN IN MARKETED FORMULATION
6